GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 789 filers reported holding GLAXOSMITHKLINE PLC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $16,716,000 | +9.4% | 400,000 | 0.0% | 11.22% | +1.3% |
| Q4 2018 | $15,284,000 | -4.9% | 400,000 | 0.0% | 11.08% | +4.0% |
| Q3 2018 | $16,068,000 | -0.3% | 400,000 | 0.0% | 10.65% | +57.2% |
| Q2 2018 | $16,124,000 | +3.2% | 400,000 | 0.0% | 6.78% | -0.3% |
| Q1 2018 | $15,628,000 | +10.1% | 400,000 | 0.0% | 6.80% | +10.1% |
| Q4 2017 | $14,188,000 | -12.6% | 400,000 | 0.0% | 6.18% | -12.8% |
| Q3 2017 | $16,240,000 | -5.8% | 400,000 | 0.0% | 7.08% | -3.4% |
| Q2 2017 | $17,248,000 | +2.3% | 400,000 | 0.0% | 7.33% | +0.6% |
| Q1 2017 | $16,864,000 | +9.5% | 400,000 | 0.0% | 7.28% | +7.7% |
| Q4 2016 | $15,404,000 | -10.7% | 400,000 | 0.0% | 6.76% | -13.6% |
| Q3 2016 | $17,252,000 | -0.5% | 400,000 | 0.0% | 7.82% | +4.4% |
| Q2 2016 | $17,336,000 | +6.9% | 400,000 | 0.0% | 7.49% | +69.5% |
| Q1 2016 | $16,220,000 | – | 400,000 | – | 4.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |